Status | Study |
Recruiting |
Study Name: Pomalidomide in Combination With Low-dose Dexamethasone or Pomalidomide in Combination With Low-dose Dexamethasone and Daratumumab in Subjects With Relapsed or Refractory Multiple Myeloma Following Lenalidomide-based Therapy in the First or Second Line Setting Condition: Multiple Myeloma Date: 2013-09-17 Interventions: Drug: Pomalidomide Other Name: |
Recruiting |
Study Name: Autologous Stem Cell Transplant Followed By Maintenance Therapy in Treating Elderly Patients With Multiple Myeloma Condition: Extramedullary Plasmacytoma Isolated Plas Date: 2013-05-06 Interventions: Drug: dexamethasone Given PO |
Active, not recruiting |
Study Name: Vaccine Therapy in Preventing Cytomegalovirus Infection in Patients With Hematological Malignancies Undergoing Donor Stem Cell Transplant Condition: Accelerated Phase Chronic Myelogenous Leukemia Adult Acute Lymphoblastic Leukemia in Remissi Date: 2012-04-26 Interventions: Biological: tetanus-CMV fusion peptide vaccine |
Withdrawn |
Study Name: Mechanical Stimulation in Preventing Bone Density Loss in Patients Undergoing Donor Stem Cell Transplant Condition: Accelerated Phase Chronic Myelogenous Leukemia Adult Acute Lymphoblastic Leukemia in Remissi Date: 2012-03-16 Interventions: Procedure: management of therapy complications |
Completed |
Study Name: Prolonged or Standard Infusion of Cefepime Hydrochloride in Treating Patients With Febrile Neutropenia Condition: Adult Acute Lymphoblastic Leukemia Adult Acute Myeloid Leukemia Date: 2011-10-21 Interventions: Drug: cefepime hydrochloride Given IV Other Names: |
Completed |
Study Name: Tivantinib in Treating Patients With Relapsed, or Relapsed and Refractory Multiple Myeloma Condition: Refractory Multiple Myeloma Date: 2011-10-04 Interventions: Drug: Tivantinib Given at a do |
Completed |
Study Name: Bone Marrow Transplantation of Patients in Remission Using Partially Matched Relative Donor Condition: Acute Myeloid Leukemia Myelodysplastic Syndromes Biphenoty Date: 2011-05-04 Interventions: Radiation: Total Body Irradiation (TBI) |
Completed |
Study Name: Ketamine Hydrochloride and Best Pain Management in Treating Cancer Patients With Neuropathic Pain Condition: Cancer Date: 2011-03-15 Interventions: Drug: ketamine hydrochloride Other: pharma |
Completed |
Study Name: A Study of ARRY-520 and Bortezomib Plus Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma Condition: Multiple Myeloma, Plasma Cell Leukemia Date: 2010-11-24 Interventions: Drug: ARRY-520, KSP(Eg5) inhibitor; intravenous |
Completed |
Study Name: A Study Evaluating the Effects of Siltuximab on the Heart in Patients With Monoclonal Gammopathy of Undetermined Significance, Smoldering Multiple Myeloma, or Indolent Multiple Myeloma Condition: Monoclonal Gammopathy of Undetermined Significance Multiple Myeloma Date: 2010-09-23 Interventions: Biological: Siltuximab 15mg/kg IV infusion every 3 weeks for 4 cycles. If applicable extended dosing of |